Breaking news
Stocks making the biggest moves midday: Shopify, Honeywell, GE Vernova, Twilio and more
Check out the companies making headlines in midday trading. Shopify — Shares surged 26% after the e-commerce platform operator posted third-quarter operating income of $283 million, higher than the $122 million in the same quarter a year ago. Shopify’s $2.16 billion revenue beat a FactSet estimate of $2.12 billion. The stock was on track for […]
Read More
Federal Reserve cuts interest rates by a quarter point
Key Points The Federal Open Market Committee lowered its benchmark overnight borrowing rate by a quarter percentage point, or 25 basis points, to a target range of 4.50%-4.75%. The vote was unanimous. Fed officials have justified the easing mode for policy as they view supporting employment becoming at least as much of a priority as […]
Read More
Former Treasury Secretary Mnuchin says Trump’s top priorities will be tax cuts, Iran sanctions and tariffs
President-elect Donald Trump likely will return to cornerstones of his previous economic platform such as tariffs, lower taxes and sanctions when he assumes office in January, his former Treasury secretary said Thursday. Steven Mnuchin, who held the post throughout Trump’s first term from 2017-21, told CNBC that he sees those items as critical to the […]
Read More
Stocks making the biggest moves midday: Super Micro Computer, Tesla, Coinbase, Planet Fitness and more
Check out the companies making headlines in midday trading. Donald Trump trades — Individual stocks viewed as trades tied to Donald Trump’s election odds surged as the Republican clinched a return to the White House. Trump Media & Technology , majority owned by Trump himself, popped nearly 5%. Tesla , whose CEO publicly backed the […]
Read More
Stocks making the biggest moves premarket: Trump Media, Hims & Hers, Palantir and more
Check out the companies making headlines before the bell. Trump Media & Technology — Shares of the TruthSocial parent, which has a majority ownership by Republican presidential candidate Donald Trump, climbed about 9% during premarket trading on Election Day . The stock has been seen as a proxy for betting on the former president’s likelihood […]
Read More
U.S. economy added just 12,000 jobs in October, impacted by hurricanes, Boeing strike
Job creation in October slowed to its weakest pace since late 2020 as the impacts of storms in the Southeast and a significant labor impasse dented the employment picture. Nonfarm payrolls increased by 12,000 for the month, down sharply from September and below the Dow Jones estimate for 100,000, the Bureau of Labor Statistics reported […]
Read More
Stocks making the biggest moves premarket: Amazon, Apple, Atlassian and more
Check out the companies making headlines before the bell. Amazon — The e-commerce giant popped 7% after posting stronger-than-expected earnings and robust cloud and advertising growth. Revenues for its Amazon Web Services grew 19% on a year-over-year basis. Apple — Shares dropped 1.6% even after the technology giant surpassed top-and-bottom line estimates for the recent […]
Read More
Key Fed inflation rate hits 2.1% in September, as expected
Inflation increased slightly in September and moved closer to the Federal Reserve’s target, according to a Commerce Department report Thursday. The personal consumption expenditures price index showed a seasonally adjusted 0.2% increase for the month, with the 12-month inflation rate at 2.1%, both in line with Dow Jones estimates. The Fed uses the PCE reading […]
Read More
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street’s expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs […]
Read More
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But […]
Read More